Selected projects

Healthcare AI Commercialisation Portfolio

A portfolio view can reveal reusable data, validation and deployment capability, but each use case needs its own intended use and evidence.

Reviewed August 2026

Direct answer

Healthcare AI Commercialisation Portfolio

A portfolio view can reveal reusable data, validation and deployment capability, but each use case needs its own intended use and evidence.

Why this matters

Healthcare organisations, investors and technology partners assessing multiple AI-enabled opportunities. need a decision framework that connects the technology or mandate to rights, evidence, capital, capability and execution. The purpose is not to create promotional volume. It is to expose the assumptions that determine whether a serious transaction or implementation programme is viable.

Build shared infrastructure without blurring product-specific risk and accountability. IIL treats that question as a stage-gated commercial decision. The conclusion should identify what is known, what remains uncertain, who owns the next action and which evidence would justify progression, redesign or pause.

Five workstreams to integrate

  • Portfolio architecture. Define the present position, evidence source, accountable owner, decision threshold and dependency on other workstreams.
  • Data governance. Define the present position, evidence source, accountable owner, decision threshold and dependency on other workstreams.
  • Validation framework. Define the present position, evidence source, accountable owner, decision threshold and dependency on other workstreams.
  • Human oversight. Define the present position, evidence source, accountable owner, decision threshold and dependency on other workstreams.
  • Commercial deployment. Define the present position, evidence source, accountable owner, decision threshold and dependency on other workstreams.

Diligence material expected

  • Use-case register. The record should be current, attributable and explicit about limitations, assumptions and superseded versions.
  • Dataset and rights map. The record should be current, attributable and explicit about limitations, assumptions and superseded versions.
  • Model-risk framework. The record should be current, attributable and explicit about limitations, assumptions and superseded versions.
  • Regulatory classification. The record should be current, attributable and explicit about limitations, assumptions and superseded versions.
  • Portfolio capital plan. The record should be current, attributable and explicit about limitations, assumptions and superseded versions.

A practical engagement sequence

  1. Confirm the legal entities, authority, mandate and non-confidential scope.
  2. Define the commercial objective, territory, rights perimeter and intended outcome.
  3. Map evidence, gaps, risks, economics and specialist-adviser requirements.
  4. Agree confidentiality, diligence access, governance and decision timetable.
  5. Move to a project-specific term sheet or implementation plan only when the principal dependencies are visible.

What a credible outcome looks like

A credible outcome is not simply an agreement to continue talking. It is a documented decision with a defined structure, responsible parties, evidence requirements, capital or capability commitments, acceptance criteria and a route for resolving variance. Where the evidence is not yet sufficient, the correct output may be a focused validation plan rather than a transaction.

Selective. Structured. International.

Discuss an investment, technology transfer or strategic partnership.

Begin with a short, non-confidential conversation. Detailed information is shared only through the appropriate qualification and confidentiality process.

Search